Sagimet Biosciences (SGMT) Retained Earnings (2023 - 2024)
Sagimet Biosciences has reported Retained Earnings over the past 2 years, most recently at -$279.1 million for Q3 2024.
- Quarterly results put Retained Earnings at -$279.1 million for Q3 2024, down 15.53% from a year ago — trailing twelve months through Sep 2024 was -$279.1 million (down 15.53% YoY), and the annual figure for FY2023 was -$249.7 million, changed.
- Retained Earnings for Q3 2024 was -$279.1 million at Sagimet Biosciences, down from -$23000.0 in the prior quarter.
- Over the last five years, Retained Earnings for SGMT hit a ceiling of -$23000.0 in Q2 2024 and a floor of -$279.1 million in Q3 2024.